Intellia Therapeutics's total assets for Q1 2026 were $758.78M, a decrease of -9.90% from the previous quarter. NTLA total liabilities were $137.84M for the fiscal quarter, a -19.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.